A new therapeutic ap-proach for treating of bisphosphonate associ-ated osteonecrosis of the jaws (BP-ONJ)
The administration of bisphosphonates is always necessary if a disease with high levels of bone resorption is given. Osteone-crosis of the jaws can arise as a contraindi-cation. This clinical picture is explained by a reduced bone turnover caused by bisphos-phonates. To date it has not been possible to develop specific therapies. The accom-plished symptomatic treatment is currently limited to antibiotic administration, mouth-washes and in the worst case operational removal of the necrotic tissue.
It was now possible to demonstrate that the administration of an agent, which is already available, can raise the viability of os-teoblasts significantly. So the agent enables to work against the osteonecrosis in an early state.
Further Information: PDF
IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50
Contact
Dr. Klaus Kobek
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
